D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 95 Citations 56,068 218 World Ranking 115 National Ranking 58
Medicine D-index 124 Citations 77,925 439 World Ranking 1320 National Ranking 792

Research.com Recognitions

Awards & Achievements

Member of the Association of American Physicians

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Disease

Michael S. Saag mainly investigates Immunology, Acquired immunodeficiency syndrome, Internal medicine, Viral load and Virology. Michael S. Saag works mostly in the field of Immunology, limiting it down to topics relating to Protease inhibitor and, in certain cases, Ritonavir. His research integrates issues of Clinical research, Cohort study, Family medicine, Intensive care medicine and Cohort in his study of Acquired immunodeficiency syndrome.

His Internal medicine research is multidisciplinary, incorporating perspectives in Meningitis, Surgery, Mycosis, Flucytosine and Cryptococcosis. His work investigates the relationship between Viral load and topics such as Maraviroc that intersect with problems in CCR5 receptor antagonist and Vicriviroc. The concepts of his Virology study are interwoven with issues in Antibody and Gp41.

His most cited work include:

  • Viral dynamics in human immunodeficiency virus type 1 infection (2971 citations)
  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study (2421 citations)
  • Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society–USA Panel (2345 citations)

What are the main themes of his work throughout his whole career to date?

Michael S. Saag spends much of his time researching Internal medicine, Acquired immunodeficiency syndrome, Immunology, Viral load and Virology. His biological study spans a wide range of topics, including Gastroenterology and Surgery. Michael S. Saag has included themes like Mortality rate, Pediatrics, Cohort study and Intensive care medicine in his Acquired immunodeficiency syndrome study.

His studies in Immunology integrate themes in fields like Disease and Antiretroviral therapy. His work in Viral load addresses issues such as Efavirenz, which are connected to fields such as Pharmacology. His study in Virus, Zidovudine and Viral replication are all subfields of Virology.

He most often published in these fields:

  • Internal medicine (38.90%)
  • Acquired immunodeficiency syndrome (30.93%)
  • Immunology (26.57%)

What were the highlights of his more recent work (between 2017-2021)?

  • Internal medicine (38.90%)
  • Acquired immunodeficiency syndrome (30.93%)
  • Cohort (16.32%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Internal medicine, Acquired immunodeficiency syndrome, Cohort, Viral load and Hazard ratio. His Internal medicine study frequently links to other fields, such as Hepatitis C virus. His Acquired immunodeficiency syndrome study incorporates themes from Marginal structural model, Regimen, Pharmacotherapy and Clinical trial.

His work carried out in the field of Regimen brings together such families of science as Intensive care medicine, Pre-exposure prophylaxis, Reverse-transcriptase inhibitor and Emtricitabine. His Viral load study combines topics from a wide range of disciplines, such as Odds ratio, Viral suppression, Interquartile range, Epidemiology and Cohort study. Michael S. Saag interconnects Proportional hazards model and Confounding in the investigation of issues within Hazard ratio.

Between 2017 and 2021, his most popular works were:

  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society–USA Panel (310 citations)
  • HIV Viral Suppression Trends Over Time Among HIV-Infected Patients Receiving Care in the United States, 1997 to 2015: A Cohort Study. (49 citations)
  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel. (45 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Disease

Michael S. Saag focuses on Internal medicine, Acquired immunodeficiency syndrome, Cohort, Viral load and Cohort study. His study on Internal medicine is mostly dedicated to connecting different topics, such as Antiretroviral therapy. The concepts of his Acquired immunodeficiency syndrome study are interwoven with issues in Coinfection and Regimen.

His Coinfection study deals with Abacavir intersecting with Intensive care medicine. His research integrates issues of Public health and Anxiety in his study of Cohort. His work deals with themes such as Odds ratio, Epidemiology and Myocardial infarction, which intersect with Viral load.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Viral dynamics in human immunodeficiency virus type 1 infection

Xiping Wei;Sajal K. Ghosh;Maria E. Taylor;Victoria A. Johnson.
Nature (1995)

4010 Citations

Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka.
PLOS ONE (2015)

3959 Citations

Antibody neutralization and escape by HIV-1

Xiping Wei;Julie M. Decker;Shuyi Wang;Huxiong Hui.
Nature (2003)

2729 Citations

Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society–USA Panel

Huldrych F Gunthard;Judith A Aberg;Joseph J Eron;Jennifer Frances Hoy.
JAMA (2008)

2345 Citations

Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection

Brandon F. Keele;Elena E. Giorgi;Elena E. Giorgi;Jesus F. Salazar-Gonzalez;Julie M. Decker.
Proceedings of the National Academy of Sciences of the United States of America (2008)

1927 Citations

Emergence of Resistant Human Immunodeficiency Virus Type 1 in Patients Receiving Fusion Inhibitor (T-20) Monotherapy

Xiping Wei;Julie M. Decker;Hongmei Liu;Zee Zhang.
Antimicrobial Agents and Chemotherapy (2002)

1723 Citations

High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR

Piatak M;Saag Ms;Yang Lc;Clark Sj.
Science (1993)

1598 Citations

Effect of early versus deferred antiretroviral therapy for HIV on survival.

Mari M. Kitahata;Stephen J. Gange;Alison G. Abraham;Barry Merriman.
The New England Journal of Medicine (2009)

1530 Citations

POTENT SUPPRESSION OF HIV-1 REPLICATION IN HUMANS BY T-20, A PEPTIDE INHIBITOR OF GP41-MEDIATED VIRUS ENTRY

J M Kilby;S Hopkins;T M Venetta;B DiMassimo.
Nature Medicine (1998)

1404 Citations

Practice Guidelines for the Management of Cryptococcal Disease

Michael S. Saag;Richard J. Graybill;Robert A. Larsen;Peter G. Pappas.
Clinical Infectious Diseases (2000)

1377 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Michael S. Saag

Julio S. G. Montaner

Julio S. G. Montaner

University of British Columbia

Publications: 312

Robert S. Hogg

Robert S. Hogg

Simon Fraser University

Publications: 240

David C. Montefiori

David C. Montefiori

Duke University

Publications: 232

Douglas D. Richman

Douglas D. Richman

University of California, San Diego

Publications: 188

Richard D. Moore

Richard D. Moore

Johns Hopkins University

Publications: 187

Kenneth H. Mayer

Kenneth H. Mayer

Fenway Health

Publications: 186

Barton F. Haynes

Barton F. Haynes

Duke University

Publications: 185

Joseph J. Eron

Joseph J. Eron

University of North Carolina at Chapel Hill

Publications: 178

David A. Cooper

David A. Cooper

Pfizer (United States)

Publications: 167

George M. Shaw

George M. Shaw

University of Pennsylvania

Publications: 164

Bruce D. Walker

Bruce D. Walker

Harvard University

Publications: 155

Steven G. Deeks

Steven G. Deeks

University of California, San Francisco

Publications: 149

Bette T. Korber

Bette T. Korber

Los Alamos National Laboratory

Publications: 145

Andrew N. Phillips

Andrew N. Phillips

University College London

Publications: 144

Beatrice H. Hahn

Beatrice H. Hahn

University of Pennsylvania

Publications: 143

Robert F. Siliciano

Robert F. Siliciano

Johns Hopkins University School of Medicine

Publications: 141

Trending Scientists

David M. Mount

David M. Mount

University of Maryland, College Park

Ramesh Sharda

Ramesh Sharda

Oklahoma State University

Giovanni Franceschini

Giovanni Franceschini

University of Modena and Reggio Emilia

Jeong Ho Cho

Jeong Ho Cho

Yonsei University

Hiroshi Takeshima

Hiroshi Takeshima

Kyoto University

Alonso Rodríguez-Navarro

Alonso Rodríguez-Navarro

Technical University of Madrid

Berhane Ghebrehiwet

Berhane Ghebrehiwet

Stony Brook University

Michael R. Trimble

Michael R. Trimble

University College London

Ulrich Ansorge

Ulrich Ansorge

University of Vienna

Diane F. Jelinek

Diane F. Jelinek

Mayo Clinic

Mary C. Davis

Mary C. Davis

Arizona State University

John V. Reynolds

John V. Reynolds

Trinity College Dublin

Randall S. Stafford

Randall S. Stafford

Stanford University

Michael W. Schwartz

Michael W. Schwartz

University of Washington

Raymond R. Tubbs

Raymond R. Tubbs

Cleveland Clinic

Edwin S. Shneidman

Edwin S. Shneidman

University of California, Los Angeles

Something went wrong. Please try again later.